Skip to main content
Top
Published in: Clinical Rheumatology 3/2018

01-03-2018 | Original Article

Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study

Authors: Jesús K. Yamamoto-Furusho, Andrea Sarmiento-Aguilar

Published in: Clinical Rheumatology | Issue 3/2018

Login to get access

Abstract

The most frequent extra-intestinal manifestation in ulcerative colitis (UC) around the world is joint involvement. There are no previous data in Latin America that is about this aspect of disease; hence, the aim of this study was to determine the frequency and factors associated to joint involvement in Mexican patients with UC. A total of 295 patients with histological diagnosis of UC were studied, divided into two groups: (1) 154 cases with at least one joint affection (arthralgia, peripheral, or axial arthropathy (sacroilitis (SI) or ankylosing spondylitis (AS))) and (2) 141 controls that had never presented any joint involvement during the clinical course of UC. Demographic, clinical, and laboratory variables were collected from the clinical records, at the time of presentation of the joint involvement for the cases and with the last information available for controls. A total of 52.2% of the patients had joint involvement, which was also the most frequent extra-intestinal manifestation (EIM). The frequency of peripheral arthralgia was 46.8% and of axial arthropathy was 5.4% (2.7% AS, 2.4% SI, and 0.3% both). The female gender (P = 0.01, OR = 3.061 95% CI: 1.311–7.15), elevated erythrocyte sedimentation rate (ESR) (P = 0.07, OR = 8.04 95% CI: 1.759–36.764), and moderate disease activity by Truelove and Witts criteria (P = 0.024, OR = 4.37 95% CI: 1.211–15.78) were factors associated at the time of presentation of the joint affection. Joint involvement is the most frequent EIM in Mexican patients with UC. The female gender, elevated ESR, and disease activity are factors associated with its presentation.
Literature
2.
go back to reference Rodríguez-Leal GA (2001) Enfermedad Inflamatoria: Epidemiología y Patogénesis. Médica Sur 8:84–89 Rodríguez-Leal GA (2001) Enfermedad Inflamatoria: Epidemiología y Patogénesis. Médica Sur 8:84–89
3.
go back to reference Yamamoto-Furusho JK (2009) Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006). J Clin Gastroenterol 43:221–224CrossRefPubMed Yamamoto-Furusho JK (2009) Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006). J Clin Gastroenterol 43:221–224CrossRefPubMed
5.
go back to reference Atzeni F, Defendenti C, Ditto MC et al (2014) Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev 13:20–23CrossRefPubMed Atzeni F, Defendenti C, Ditto MC et al (2014) Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev 13:20–23CrossRefPubMed
6.
go back to reference Pérez-Alamino R, Maldonado-Ficco H, Maldonado-Cocco JA (2016) Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol 35:291–296CrossRefPubMed Pérez-Alamino R, Maldonado-Ficco H, Maldonado-Cocco JA (2016) Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol 35:291–296CrossRefPubMed
7.
go back to reference Assche GV, Dignass A, Bokemeyer B et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7:1–33CrossRefPubMed Assche GV, Dignass A, Bokemeyer B et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7:1–33CrossRefPubMed
9.
go back to reference Barreiro M, Dominguez JE, Nuñez MC et al (2007) Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol 19:73–78CrossRef Barreiro M, Dominguez JE, Nuñez MC et al (2007) Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol 19:73–78CrossRef
10.
go back to reference Palm O, Bernklev T, Moum B, Gran JT (2005) Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol 32:1755–1759PubMed Palm O, Bernklev T, Moum B, Gran JT (2005) Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol 32:1755–1759PubMed
11.
go back to reference Al-Jarallah K, Shehab D, Al-Azmi W, Al-Fadli A (2013) Rheumatic complications of inflammatory bowel diseaseamong Arabs: a hospital-based study in Kuwait. Int J Rheum Dis 16:134–138CrossRefPubMed Al-Jarallah K, Shehab D, Al-Azmi W, Al-Fadli A (2013) Rheumatic complications of inflammatory bowel diseaseamong Arabs: a hospital-based study in Kuwait. Int J Rheum Dis 16:134–138CrossRefPubMed
12.
go back to reference Salvarani C, Vlachonnikolis I, Van Der Heijde DM et al (2001) Mucoskeletal manifestations in a population based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313CrossRefPubMed Salvarani C, Vlachonnikolis I, Van Der Heijde DM et al (2001) Mucoskeletal manifestations in a population based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313CrossRefPubMed
13.
go back to reference Bourikas LA, Papadakis KA (2009) Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 15:1915–1924CrossRefPubMed Bourikas LA, Papadakis KA (2009) Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 15:1915–1924CrossRefPubMed
14.
go back to reference Leclerc-Jacob S, Lux G, Rat AC et al (2014) The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther 39:957–962CrossRefPubMed Leclerc-Jacob S, Lux G, Rat AC et al (2014) The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther 39:957–962CrossRefPubMed
15.
go back to reference Van Der Heijde D, Sieper J, Maksymowych WP et al (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70:905–908CrossRefPubMed Van Der Heijde D, Sieper J, Maksymowych WP et al (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70:905–908CrossRefPubMed
16.
go back to reference Denmark VK, Mayer L (2013) Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update. Expert Rev Clin Immunol 9:77–92CrossRefPubMed Denmark VK, Mayer L (2013) Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update. Expert Rev Clin Immunol 9:77–92CrossRefPubMed
17.
go back to reference Atzeni F, Benucci M, Sallì S, Bongiovanni S et al (2013) Different effects of biological drugs in rheumatoid arthritis. Autoimmun Rev 12:575–579CrossRefPubMed Atzeni F, Benucci M, Sallì S, Bongiovanni S et al (2013) Different effects of biological drugs in rheumatoid arthritis. Autoimmun Rev 12:575–579CrossRefPubMed
18.
go back to reference Atzeni F, Talotta R, Benucci M et al (2013) Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev 12:703–708CrossRefPubMed Atzeni F, Talotta R, Benucci M et al (2013) Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev 12:703–708CrossRefPubMed
19.
go back to reference Olivieri I, D'angelo S, Padula A et al (2013) Can we reduce the dosage of biologics in spondyloarthritis? Autoimmun Rev 12:691–693CrossRefPubMed Olivieri I, D'angelo S, Padula A et al (2013) Can we reduce the dosage of biologics in spondyloarthritis? Autoimmun Rev 12:691–693CrossRefPubMed
20.
go back to reference Roberts H, Rai SN, Pan J et al (2014) Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion 90:122–129CrossRefPubMed Roberts H, Rai SN, Pan J et al (2014) Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion 90:122–129CrossRefPubMed
21.
go back to reference Yuksel I, Ataseven H, Basar O et al (2011) Peripheral arthritis in the course of inflammatory bowel diseases. Dig Dis Sci 56:183–187CrossRefPubMed Yuksel I, Ataseven H, Basar O et al (2011) Peripheral arthritis in the course of inflammatory bowel diseases. Dig Dis Sci 56:183–187CrossRefPubMed
22.
go back to reference Alharbi OR, Azzam NA, Almalki AS et al (2014) Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol 20:17525–17531CrossRefPubMedPubMedCentral Alharbi OR, Azzam NA, Almalki AS et al (2014) Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol 20:17525–17531CrossRefPubMedPubMedCentral
23.
go back to reference Zippi M, Corrado C, Pica R et al (2014) Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 20:17463–17467CrossRefPubMedPubMedCentral Zippi M, Corrado C, Pica R et al (2014) Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 20:17463–17467CrossRefPubMedPubMedCentral
24.
go back to reference Christodoloulou DK, Katsanos KH, Kitsanou M et al (2002) Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis 34:781–786CrossRef Christodoloulou DK, Katsanos KH, Kitsanou M et al (2002) Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis 34:781–786CrossRef
26.
go back to reference Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391CrossRefPubMedPubMedCentral Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391CrossRefPubMedPubMedCentral
27.
go back to reference Dorofeyev AE, Vasilenko IV, Rassokhina OA (2009) Joint extraintestinal manifestations in ulcerative colitis. Dig Dis 27:502–510CrossRefPubMed Dorofeyev AE, Vasilenko IV, Rassokhina OA (2009) Joint extraintestinal manifestations in ulcerative colitis. Dig Dis 27:502–510CrossRefPubMed
28.
29.
go back to reference Holden W, Orchard T, Wordsworth P (2003) Enteropathic arthritis. Rheum Dis 29:513–530 Holden W, Orchard T, Wordsworth P (2003) Enteropathic arthritis. Rheum Dis 29:513–530
30.
go back to reference Balbir-Gurman A, Schapira D, Nahir M (2001) Arthritis related to ileal pouchitis following total proctocolectomy for UC. Semin Arthritis Rheum 30:242–248CrossRefPubMed Balbir-Gurman A, Schapira D, Nahir M (2001) Arthritis related to ileal pouchitis following total proctocolectomy for UC. Semin Arthritis Rheum 30:242–248CrossRefPubMed
31.
32.
go back to reference Elia PP, Fogaça HS, Barros RG (2007) Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the “Clementino Fraga Filho” University Hospital, Rio de Janeiro, RJ, Brazil. Arq Gastroenterol 44:332–339CrossRefPubMed Elia PP, Fogaça HS, Barros RG (2007) Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the “Clementino Fraga Filho” University Hospital, Rio de Janeiro, RJ, Brazil. Arq Gastroenterol 44:332–339CrossRefPubMed
Metadata
Title
Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study
Authors
Jesús K. Yamamoto-Furusho
Andrea Sarmiento-Aguilar
Publication date
01-03-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3834-z

Other articles of this Issue 3/2018

Clinical Rheumatology 3/2018 Go to the issue